Real-time enrollment status for this neuroblastoma clinical trial
Current Status
Recruiting
Checked: October 17, 2026 at 12:18 AM UTC
| NCT Number | NCT03721068 |
| Recruiting Status | Recruiting |
| Condition | Neuroblastoma |
| Phase | PHASE1 |
| Target Enrollment | 18 participants |
| Active Locations | 2 sites in the US |
| Sponsor | UNC Lineberger Comprehensive Cancer Center |
| Last Updated on CT.gov | March 27, 2026 (Mar 27, 2026) |
As of October 17, 2026: Clinical trial NCT03721068 is currently recruiting participants. This phase1 study for neuroblastoma is actively seeking new participants at 2 locations across the United States. The study is sponsored by UNC Lineberger Comprehensive Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT03721068 is actively recruiting participants as of October 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03721068 was last updated Mar 27, 2026 (March 27, 2026). HelloStudys verifies this status automatically.